Skip to main content
Back to Show
PBS News Hour

What we know about remdesivir study and COVID-19 antibodies

Testing, both for active cases of COVID-19 and for antibodies indicating prior exposure to the disease, will be critical to resuming economic activity. In addition, scientists are racing to develop therapies for people who do get infected -- especially those who become seriously ill. Science correspondent Miles O’Brien joins Judy Woodruff to discuss the latest on COVID-19 testing and treatment.

Support Provided By
Season
November 23, 2024 - PBS News Weekend full episode
26:45
November 23, 2024 - PBS News Weekend full episode
November 22, 2024 - PBS News Hour full episode
57:46
November 22, 2024 - PBS News Hour full episode
November 21, 2024 - PBS News Hour full episode
56:41
November 21, 2024 - PBS News Hour full episode
November 20, 2024 - PBS News Hour full episode
57:46
November 20, 2024 - PBS News Hour full episode
November 19, 2024 - PBS News Hour full episode
57:46
November 19, 2024 - PBS News Hour full episode
November 18, 2024 - PBS News Hour full episode
57:46
November 18, 2024 - PBS News Hour full episode
November 17, 2024 - PBS News Weekend full episode
26:45
November 17, 2024 - PBS News Weekend full episode
November 16, 2024 - PBS News Weekend full episode
26:45
November 16, 2024 - PBS News Weekend full episode
November 15, 2024 - PBS News Hour full episode
57:46
November 15, 2024 - PBS News Hour full episode
November 14, 2024 - PBS News Hour full episode
57:46
November 14, 2024 - PBS News Hour full episode
November 13, 2024 - PBS News Hour full episode
57:46
November 13, 2024 - PBS News Hour full episode
November 12, 2024 - PBS News Hour full episode
57:46
November 12, 2024 - PBS News Hour full episode
Active loading indicator